MCL Field Gaining Better Understanding of Patient Subsets to Guide Treatment   

MCL Field Gaining Better Understanding of Patient Subsets to Guide Treatment

There has been a shift in the treatment landscape for mantle cell lymphoma (MCL), according to Andre Goy, M.D. Clinical trials are now investigating options for various subsets of patients based on their ECOG status, molecular features, and other identifying factors.

READ FULL ARTICLE ON TARGETEDONC.COM

We use cookies to improve your experience. Please read our Privacy Policy or click Accept.
X